Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease, including heart attack. Testing for lipoprotein(a) is even a recommendation in some guidelines to identify patients at risk for early heart disease. But is lipoprotein(a) a risk factor for venous thrombosis as well? A recent publication from my group explores the links between lipoprotein(a) and blood clots.”
Read the full article here.
Title: Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Authors: Mariana B Pfeferman, Sina Rashedi, Gregory Y H Lip, Christian Weber, Michelle L O’Donoghue, Steven Nissen, Stephen J Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z Goldhaber, Gregory Piazza, Behnood Bikdeli
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025